arrow
返回
M

Mark G. Currie

harvard university medical affiliates

69H指数
313论文数
2.1W被引数
收录论文 88
发表时间
FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats
err2024-09-30
err0
errOAAI
errLarauche, Muriel; Mulak, Agata; Ha, Chrysanthy; Million, Mulugeta; Arnett, Stacy; Germano, Peter; Pearson, James P.; Currie, Mark G.; Tache, Yvette
err分享
err收藏
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
err2021-09-18
err17
errOAAI
errCorreia, Susana S.; Liu, Guang; Jacobson, Sarah; Bernier, Sylvie G.; Tobin, Jenny V.; Schwartzkopf, Chad D.; Atwater, Emily; Lonie, Elisabeth; Rivers, Sam; Carvalho, Andrew; Germano, Peter; Tang, Kim; Iyengar, Rajesh R.; Currie, Mark G.; Hadcock, John R.; Winrow, Christopher J.; Jones, Juli E.
err分享
err收藏
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease A Randomized Placebo-Controlled Clinical Trial
err2020-12-16
err25
errOAAI
errHanrahan, John P.; de Boer, Ian H.; Bakris, George L.; Wilson, Phebe J.; Wakefield, James D.; Seferovic, Jelena P.; Chickering, Jennifer G.; Chien, Yueh-tyng; Carlson, Kenneth; Cressman, Michael D.; Currie, Mark G.; Milne, G. Todd; Profy, Albert T.
err分享
err收藏
Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells
err2020-10-01
err15
errOAAI
errLiu, Guang; Shea, Courtney M.; Jones, Juli E.; Price, Gavrielle M.; Warren, William; Lonie, Elisabeth; Yan, Shu; Currie, Mark G.; Profy, Albert T.; Masferrer, Jaime L.; Zimmer, Daniel P.
err分享
err收藏
Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease
err2020-06-01
err2
PREAI
errHanrahan, John P.; de Boer, Ian; Bakris, George; Wilson, Phebe; Wakefield, James D.; Seferovic, Jelena P.; Chickering, Jennifer; Cressman, Michael; Currie, Mark; Milne, George T.; Profy, Albert T.
err分享
err收藏
Metabolic Effects of Praliciguat, Empagliflozin, and Their Combination in Rats with Programmed Hypertension and Early Exposure to High-Fat Diet
err2020-06-01
err0
PREAI
errSchwartzkopf, Chad; Ribo, Virginia Reverte; Rodriguez, Francisca; Oltra, Lidia; Moreno Ayuso, Juan Manuel; Llinas, M. Teresa; Nicolas, Alejandro S.; Shea, Courtney; Currie, Mark; Jones, Juli E.; Buys, Emmanuel S.; Masferrer, Jaime; Salazar Aparicio, Francisco Javier
err分享
err收藏
err分享
err收藏
IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Re flux Disease in a Randomized Trial
err2020-06-01
err33
errOAAI
errVaezi, Michael F.; Fass, Ronnie; Vakil, Nimish; Reasner, David S.; Mittleman, Robert S.; Hall, Michael; Shao, James Z.; Chen, Yan; Lane, Lara; Gates, Amy M.; Currie, Mark G.
err分享
err收藏
Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure
err2020-01-01
err33
errOAAI
errShea, Courtney M.; Price, Gavrielle M.; Liu, Guang; Sarno, Renee; Buys, Emmanuel S.; Currie, Mark G.; Masferrer, Jaime L.
err分享
err收藏
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
err2019-12-19
err23
errOAAI
errHanrahan, John P.; Seferovic, Jelena P.; Wakefield, James D.; Wilson, Phebe J.; Chickering, Jennifer G.; Jung, Joon; Carlson, Kenneth E.; Zimmer, Daniel P.; Frelinger, Andrew L., III; Michelson, Alan D.; Morrow, Linda; Hall, Michael; Currie, Mark G.; Milne, G. Todd; Profy, Albert T.
err分享
err收藏
Praliciguat, a Clinical-Stage sGC Stimulator, Improves Insulin Sensitivity, Lipid Tolerance, and Energy Utilization in a Mouse Diet-Induced Obesity Model Housed at Thermoneutrality
err2019-06-01
err1
PREAI
errSchwartzkopf, Chad; Hadcock, John; Roux, Julien; Liu, Guang; Shea, Courtney; Currie, Mark; Milne, G. Todd; Masferrer, Jaime; Jones, Juli E.
err分享
err收藏
sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH
err2019-05-13
err40
errOAAI
errHall, Katherine C.; Bernier, Sylvie G.; Jacobson, Sarah; Liu, Guang; Zhang, Ping Y.; Sarno, Renee; Catanzano, Victoria; Currie, Mark G.; Masferrer, Jaime L.
err分享
err收藏
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis利那洛肽治疗慢性特发性便秘和便秘型肠易激综合征的安全性和耐受性: 合并3期分析
err2019-02-18
err13
errOAAI
errNee, Judy W.; Johnston, Jeffrey M.; Shea, Elizabeth P.; Walls, Courtney E.; Tripp, Kenneth; Shiff, Steven; Fox, Susan M.; Bochenek, Wieslaw; Weissman, Darren; Currie, Mark G.; Lembo, Anthony J.
err分享
err收藏
High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan
err2018-10-23
err32
errOAAI
errFukudo, Shin; Miwa, Hiroto; Nakajima, Atsushi; Kinoshita, Yoshikazu; Kosako, Masanori; Hayashi, Kenta; Akiho, Hiraku; Kuroishi, Kentaro; Johnston, Jeffrey M.; Currie, Mark; Ohkusa, Toshifumi
err分享
err收藏
A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan
err2018-08-22
err23
errOAAI
errFukudo, Shin; Miwa, Hiroto; Nakajima, Atsushi; Haruma, Ken; Kosako, Masanori; Nakagawa, Ayako; Akiho, Hiraku; Yamaguchi, Yusuke; Johnston, Jeffrey M.; Currie, Mark; Kinoshita, Yoshikazu
err分享
err收藏
Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study
err2018-08-07
err13
errOAAI
errFukudo, Shin; Miwa, Hiroto; Nakajima, Atsushi; Kinoshita, Yoshikazu; Kosako, Masanori; Nakagawa, Ayako; Akiho, Hiraku; Kuroishi, Kentaro; Johnston, Jeffrey M.; Currie, Mark; Ohkusa, Toshifumi
err分享
err收藏
Rapid Dose Escalation Study of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in Patients with Diabetes and Hypertension
err2018-07-01
err1
PREAI
errHanrahan, John P.; Wakefield, James D.; Wilson, Phebe J.; Zimmer, Daniel P.; Mihova, Marina; Chickering, Jennifer; Ruff, Dennis; Hall, Michael L.; Currie, Mark; Milne, G. Todd; Profy, Albert T.
err分享
err收藏
Fourteen-Day Study of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in Patients with Diabetes and Hypertension
err2018-07-01
err4
PREAI
errHanrahan, John P.; Wakefield, James D.; Wilson, Phebe J.; Miller, Paul; Chickering, Jennifer; Morrow, Linda; Hall, Michael L.; Currie, Mark; Milne, G. Todd; Profy, Albert T.
err分享
err收藏
Praliciguat, a Clinical-Stage sGC Stimulator, Improved Glucose Tolerance and Insulin Sensitivity and Lowered Triglycerides in a Mouse Diet-Induced Obesity Model
err2018-07-01
err0
PREAI
errSchwartzkopf, Chad D.; Hadcock, John; Jones, Juli E.; Currie, Mark; Milne, George T.; Masferrer, Jaime
err分享
err收藏
Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease
err2018-06-01
err54
errOAAI
errTobin, Jenny, V; Zimmer, Daniel P.; Shea, Courtney; Germano, Peter; Bernier, Sylvie G.; Liu, Guang; Long, Kim; Miyashiro, Joy; Ranganath, Sheila; Jacobson, Sarah; Tang, Kim; Im, G-Yoon Jamie; Sheppeck, James, II; Moore, Joel D.; Sykes, Kristine; Wakefield, James; Sarno, Renee; Banijamali, Ali R.; Profy, Albert T.; Milne, G. Todd; Currie, Mark G.; Masferrer, Jaime L.
err分享
err收藏